PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Total fruit extract (CSFTE) reduced serum uric acid, creatinine, and blood urea nitrogen levels in rats [PMID:38393010]
Polysaccharides demonstrated analgesic and anti-arthritic activity, reducing paw edema in CFA-induced rats [PMID:35401173]; network pharmacology suggests chondroprotective effects via targets like AKT1 and IL-6 [PMID:37178981]
Fruit extract (CSFE) improved depressive-like behaviors in corticosterone-induced mice, reducing immobility in tail suspension and forced swim tests [PMID:38892026]
Butylchlorogenate from C. speciosa shows potential in managing UC by suppressing NLRP3 inflammasome activation [PMID:41005055]
Evidence summary
PubMed sources
- 1.PMID: 38062238 (2023) — Phytochemistry and pharmacology of plants in the genus Chaenomeles. · Archives of pharmacal research
- 2.PMID: 30622618 (2018) — Phytochemical and Pharmacological Properties of Chaenomeles speciosa: An Edible Medicinal Chinese Mugua. · Evidence-based complementary and alternative medicine : eCAM
- 3.PMID: 28895387 (2017) — Chaenomeles – health promoting benefits. · Roczniki Panstwowego Zakladu Higieny
- 4.PMID: 38998935 (2024) — Recent Advances in Polysaccharides from Chaenomeles speciosa (Sweet) Nakai.: Extraction, Purification, Structural Characteristics, Health Benefits, and Applications. · Molecules (Basel, Switzerland)
- 5.PMID: 41005055 (2025) — Butylchlorogenate from Chaenomeles speciosa alleviates ulcerative colitis via suppressing NLRP3 inflammasome activation and remodeling intestinal homeostasis.